Science Explorer Back to mapMap
Institution · Wilhelminen Hospital

Most cited papers from Wilhelminen Hospital

What are the most cited papers from Wilhelminen Hospital?

The most cited paper from Wilhelminen Hospital is "International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma" (Shaji Kunnathu Kumar et al., 2016), with 3,102 citations. Next come "Heart Failure with Preserved and Reduced Ejection Fraction in Hemodialysis Patients: Prevalence, Disease Prediction and Prognosis" (2,819) and "International uniform response criteria for multiple myeloma" (2,662).

Showing 50 of 60 papers. Every paper with more than 387 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma Shaji Kunnathu Kumar et al. · The Lancet Oncology 26 Jul 2016 3,102
2 Heart Failure with Preserved and Reduced Ejection Fraction in Hemodialysis Patients: Prevalence, Disease Prediction and Prognosis Marlies Antlanger, Stefan Aschauer, Chantal Kopecky et al. · Kidney & Blood Pressure Research Open access 2017 2,819
3 International uniform response criteria for multiple myeloma Brian G.M. Durie et al. · Leukemia 20 Jul 2006 2,662
4 European Hernia Society guidelines on the treatment of inguinal hernia in adult patients Maarten P. Simons, Theo J. Aufenacker, Morten Bay‐Nielsen et al. · Hernia Open access 27 Jul 2009 1,621
5 Breast cancer in China Lei Fan, Kathrin Strasser‐Weippl, Jun-Jie Li et al. · The Lancet Oncology 25 May 2014 1,439
6 Carfilzomib, Lenalidomide, and Dexamethasone for Relapsed Multiple Myeloma A. Keith Stewart et al. · New England Journal of Medicine Open access 6 Dec 2014 1,342
7 COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study Florian Götzinger et al. · The Lancet Child & Adolescent Health Open access115 authors 25 Jun 2020 1,307
8 PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock Holger Thiele et al. · New England Journal of Medicine Open access 30 Oct 2017 1,209
9 Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation John W. Eikelboom, Lars C. Wallentin, Stuart J. Connolly et al. · Circulation Open access 17 May 2011 1,082
10 Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1 S. Vincent Rajkumar et al. · Blood Open access 4 Feb 2011 1,047
11 Ticagrelor with or without Aspirin in High-Risk Patients after PCI Roxana Mehran et al. · New England Journal of Medicine Open access 26 Sep 2019 1,040
12 Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis George Βertsias et al. · Annals of the Rheumatic Diseases Open access Aug 2012 1,030
13 Apixaban with Antiplatelet Therapy after Acute Coronary Syndrome John Hunter Alexander et al. · New England Journal of Medicine Open access 24 Jul 2011 1,002
14 Lipoprotein(a), PCSK9 Inhibition, and Cardiovascular Risk Michelle L. O’Donoghue, Sergio Fazio, Robert Patrick Giugliano et al. · Circulation Open access 17 Jan 2019 997
15 European Myeloma Network Guidelines for the Management of Multiple Myeloma-related Complications Evangelos Terpos et al. · Haematologica Open access Oct 2015 994
16 The European Cancer Anaemia Survey (ECAS): A large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients Heinz Ludwig, Simon Van Belle, Peter J. Barrett-Lee et al. · European Journal of Cancer 17 Sep 2004 939
17 Histopathologic Classification of ANCA-Associated Glomerulonephritis Annelies E. Berden, Franco Ferrario, E. Christiaan Hagen et al. · Journal of the American Society of Nephrology 8 Jul 2010 918
18 A Mutation in VPS35, Encoding a Subunit of the Retromer Complex, Causes Late-Onset Parkinson Disease Alexander A. Zimprich et al. · The American Journal of Human Genetics Open access Jul 2011 915
19 ERS guidelines on the diagnosis and treatment of chronic cough in adults and children Alyn H. Morice, Eva Millqvist, Kristina Biekšienė et al. · European Respiratory Journal Open access 12 Sep 2019 907
20 Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management Robert A. Kyle et al. · Leukemia Open access 22 Apr 2010 894
21 Prasugrel versus Clopidogrel for Acute Coronary Syndromes without Revascularization Matthew T. Roe et al. · New England Journal of Medicine Open access 26 Aug 2012 884
22 Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Philippe Moreau, Jesús F. San Miguel, Pieter Sonneveld et al. · Annals of Oncology Open access 6 Apr 2017 882
23 Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre study Meletios Athanasios Dimopoulos et al. · The Lancet Oncology Open access 5 Dec 2015 861
24 Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma Antonio Pierangelo Palumbo et al. · Leukemia 20 Dec 2007 846
25 International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders Angela Dispenzieri et al. · Leukemia Open access 20 Nov 2008 817
26 Fibrinolysis or Primary PCI in ST-Segment Elevation Myocardial Infarction Paul W. Armstrong et al. · New England Journal of Medicine Open access 10 Mar 2013 800
27 Lenalidomide and Dexamethasone in Transplant-Ineligible Patients with Myeloma Lotfi Benboubker et al. · New England Journal of Medicine Open access 3 Sep 2014 798
28 Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report Antonio Pierangelo Palumbo et al. · Blood Open access 28 Jan 2015 781
29 High Plasma Levels of Factor VIII and the Risk of Recurrent Venous Thromboembolism Paul Alexander Kyrle, Erich Minar, Mirko Hirschl et al. · New England Journal of Medicine Open access 17 Aug 2000 770
30 Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes Pierluigi Tricoci et al. · New England Journal of Medicine Open access 13 Nov 2011 757
31 Guidelines for laparoscopic (TAPP) and endoscopic (TEP) treatment of inguinal Hernia [International Endohernia Society (IEHS)] R. Bittner et al. · Surgical Endoscopy Open access 12 Jul 2011 754
32 Treat-to-target in systemic lupus erythematosus: recommendations from an international task force Ronald van Vollenhoven et al. · Annals of the Rheumatic Diseases Open access 17 Apr 2014 743
33 Management of patients with multiple myeloma in the era of COVID-19 pandemic: a consensus paper from the European Myeloma Network (EMN) Evangelos Terpos, Monika Martha Engelhardt, Gordon C Cook et al. · Leukemia Open access 22 May 2020 741
34 Gait disorders in adults and the elderly Walter Pirker, Regina Katzenschlager · Wiener klinische Wochenschrift Open access 21 Oct 2016 679
35 Prehospital Ticagrelor in ST-Segment Elevation Myocardial Infarction Gilles Montalescot et al. · New England Journal of Medicine Open access Sep 2014 663
36 Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years Paul Edward Goss, James N. Ingle, Kathleen I. Pritchard et al. · New England Journal of Medicine Open access 5 Jun 2016 656
37 European Hernia Society guidelines on the closure of abdominal wall incisions Filip E. Muysoms et al. · Hernia Open access 24 Jan 2015 654
38 Guidelines for laparoscopic treatment of ventral and incisional abdominal wall hernias (International Endohernia Society (IEHS)—Part 1 R. Bittner et al. · Surgical Endoscopy Open access 11 Oct 2013 653
39 General principles for the clinical use of the LCP Michael A. Wagner · Injury 22 Oct 2003 593
40 Age-Associated Loss of OPA1 in Muscle Impacts Muscle Mass, Metabolic Homeostasis, Systemic Inflammation, and Epithelial Senescence Caterina Tezze, Vanina Romanello, María Andrea Desbats et al. · Cell Metabolism Open access 25 May 2017 587
41 The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group Nelson Leung et al. · Nature Reviews Nephrology ReviewOpen access 3 Dec 2018 553
42 International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders Jens Hillengaß et al. · The Lancet Oncology Open access 29 May 2019 519
43 Report of the European Myeloma Network on multiparametric flow cytometry in multiple myeloma and related disorders Andy C. Rawstron et al. · Haematologica Open access 11 Feb 2008 518
44 The O nset of N onmotor S ymptoms in P arkinson's disease ( T he ONSET PD S tudy) Claustre Pont‐Sunyer et al. · Movement Disorders Dec 2014 512
45 Challenges to effective cancer control in China, India, and Russia Paul Edward Goss et al. · The Lancet Oncology Apr 2014 510
46 Planning cancer control in Latin America and the Caribbean Paul Edward Goss et al. · The Lancet Oncology Open access Apr 2013 505
47 Bivalirudin Started during Emergency Transport for Primary PCI Philippe Gabríel Steg et al. · New England Journal of Medicine Open access 30 Oct 2013 499
48 Diagnostic delay for endometriosis in Austria and Germany: causes and possible consequences Gernot Hudelist, Nadja Fritzer, Almut E. Thomas et al. · Human Reproduction 17 Sep 2012 492
49 The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm Homie A. Razavi et al. · Journal of Viral Hepatitis Open access 8 Apr 2014 489
50 The Risk of Recurrent Venous Thromboembolism in Men and Women Paul Alexander Kyrle, Erich Minar, Christine Bialonczyk et al. · New England Journal of Medicine Open access 16 Jun 2004 480

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.